๐ฆ Active against aerobic and anaerobic Gram-positive bacteria, including multi-resistant Staphylococcus aureus (MRSA), though resistance is increasingly reported.
๐ About
Always check the BNF link here.
- ๐ Glycopeptide antibiotic, alternative to vancomycin.
- ๐งช Levels must be monitored closely in high-risk groups.
โ๏ธ Action
- ๐ Glycopeptide โ bactericidal activity via inhibition of cell wall synthesis.
๐ Indications
- ๐ฅ Serious Gram-positive infections, including infective endocarditis.
- ๐ฉบ Staphylococcus aureus infections (including MRSA).
- ๐ง Dialysis-associated peritonitis.
- ๐ Alternative to vancomycin when intolerance or toxicity occurs.
๐ Dose (check BNF / datasheet)
- ๐ 400 mg IM/IV every 12 hrs for 1โ3 doses, then 200 mg OD (maintenance).
- ๐ฏ Target trough: 10โ60 mg/L (15โ60 mg/L in endocarditis).
- ๐ง Severe infections / endocarditis: 10 mg/kg 12-hrly for 3โ5 doses, then 10 mg/kg OD.
- ๐ฆด Bone/joint infections: 12 mg/kg 12-hrly for 3โ5 doses, then 12 mg/kg OD.
- ๐ฅ MRSA, severe burns:
โข <70 kg โ 400 mg 12-hrly for 3 doses, then 400 mg OD.
โข >70 kg โ 6 mg/kg 12-hrly for 3 doses, then 6 mg/kg OD.
- ๐ฉ C. difficile infection: 100โ200 mg PO every 12 hrs for 10โ14 days.
๐ Interactions
- ๐ Ototoxicity risk โ with aminoglycosides or loop diuretics.
- ๐ง Nephrotoxicity risk โ with other nephrotoxic drugs (e.g. ciclosporin, amphotericin B).
โ ๏ธ Cautions
- ๐ง Renal impairment (dose adjustment needed).
- ๐ต Elderly patients more susceptible to nephro/ototoxicity.
- ๐งช Monitor teicoplanin levels and renal function in: severe burns, sepsis, deep staphylococcal infection, endocarditis, renal failure, elderly.
โ Contraindications
- ๐ซ Hypersensitivity to teicoplanin or vancomycin (cross-reactivity possible).
- โ ๏ธ Avoid or closely monitor with concurrent nephrotoxic/ototoxic agents.
๐ฅ Side Effects
- ๐คข GI: nausea, vomiting, diarrhoea.
- ๐ฉธ Haematological: eosinophilia, leucopenia, neutropenia, thrombocytopenia.
- ๐ Ototoxicity: vestibular disorders, tinnitus, hearing loss.
- ๐ง Nephrotoxicity (rare but serious).
๐ References